Anticancer Drugs
April 2024
Objective: To study the diagnostic value of mRNA expression in urinary exocrine body in bladder cancer.
Methods: From February 2022 to December 2022, 60 patients diagnosed with bladder cancer by pathology in the Department of Urology, Affiliated Hospital of Chengde Medical University were selected as the case group. In total, 40 healthy subjects receiving physical examinations were selected as the control group.
Renal cell carcinoma (RCC) is the most common form of kidney cancer. Vascular endothelial growth factor-C (VEGF-C) and its receptor, VEGFR-3, are involved in lymphangiogenesis. The aim of the present study was to investigate the expression levels of VEGF-C and VEGFR-3 in RCC, and their association with lymphatic vessel density (LVD) and lymph node metastasis.
View Article and Find Full Text PDFCancer Manag Res
December 2020
Aim: Bladder cancer (BLCA) is an urogenital system tumor with a high morbidity. We aimed to explore the function and potential mechanism of α-E-catenin (CTNNA1) in BLCA.
Methods: The CTNNA1 expression in BLCA tissues was detected using qRT-PCR and immunohistochemistry.